TBTC Study 27/28 PK: Pharmacokinetic Issues in the Use of Moxifloxacin for Treatment of Tuberculosis
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2018
At a glance
- Drugs Moxifloxacin (Primary) ; Isoniazid
- Indications Tuberculosis
- Focus Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 18 Apr 2008 Status changed from in progress to completed, from clinicaltrials.gov record.
- 20 Sep 2007 Status changed from recruiting to in progress.